Search

Your search keyword '"Pharmacogenomics -- Health aspects"' showing total 30 results
Start Over Descriptor "Pharmacogenomics -- Health aspects" Topic business
30 results on '"Pharmacogenomics -- Health aspects"'

1. Global Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies Report 2020: Description of 35 Companies Involved with Their Collaborations in this Area

Subjects
Precision medicine -- Health aspects, Drugs -- Health aspects, Pharmacogenomics -- Health aspects, Banking, finance and accounting industries, Business
Abstract

Dublin, Nov 03, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'Therapeutic Drug Monitoring - Technologies, Markets & Companies' report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report [...]

Published
2020

2. Genomind Announces Major Industry-Leading HLA-A Test Innovation on its Comprehensive Mental Health Pharmacogenetics (PGx) Test, Increasing Utility for Tens of Thousands of Clinicians and Patients

Subjects
Oxcarbazepine -- Health aspects, Mental health -- Health aspects, Medical care quality -- Health aspects, Pharmacogenomics -- Health aspects, Mental health services -- Innovations, Health insurance industry -- Innovations -- Health aspects, HLA antigens -- Health aspects, Business, Business, international, World Health Organization -- Innovations
Abstract

Innovation almost completely eliminates the 40% false positive rate traditionally associated with HLA-A testing, making Genomind the only mental health PGx test with this new capability Combined with recent major [...]

Published
2020

3. Green Shield Canada and HBM+ announce positive results from clinical trial of pharmacogenomics-led treatment for patients with mental health conditions

Subjects
Clinical trials -- Health aspects, Mental health -- Health aspects, Pharmacogenomics -- Health aspects, Banking, finance and accounting industries, Business
Abstract

TORONTO, June 16, Jun 16, 2020 (GLOBE NEWSWIRE via COMTEX) -- As part of ongoing efforts to drive patient health outcomes and maximize the value of drug spend, Green Shield [...]

Published
2020

4. Green Shield Canada invests in GenXys to harness power of pharmacogenomics

Subjects
Precision medicine -- Health aspects, Pharmacogenomics -- Health aspects, Power (Philosophy), Backup software, Prescription writing, Company investment, Banking, finance and accounting industries, Business
Abstract

TORONTO, May 26, May 26, 2020 (GLOBE NEWSWIRE via COMTEX) -- With the concept of personalized medicine gathering momentum across the health care environment, Green Shield Canada (GSC) is pleased [...]

Published
2020

5. Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies to 2028 - ResearchAndMarkets.com

Subjects
Precision medicine -- Health aspects, Memantine -- Health aspects, Anticonvulsants -- Health aspects, Aripiprazole -- Health aspects, Pharmacogenomics -- Health aspects, Drug abuse, Illegal drugs, Technology, Levetiracetam, Primidone, Lamotrigine, Lacosamide, Patient monitoring equipment, Business, Business, international
Abstract

DUBLIN -- The 'Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies to 2028' report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report deals with therapeutic drug monitoring, [...]

Published
2020

6. Global Therapeutic Drug Monitoring Industry Insights, 2018-2028: Unmet Needs and Strategies for Development

Subjects
Precision medicine -- Health aspects, Drugs -- Health aspects, Memantine -- Health aspects, Anticonvulsants -- Health aspects, Aripiprazole -- Health aspects, Pharmacogenomics -- Health aspects, Pharmaceutical industry -- Health aspects, Levetiracetam, Primidone, Illegal drugs, Technology, Lamotrigine, Lacosamide, Patient monitoring equipment, Banking, finance and accounting industries, Business
Abstract

Dublin, March 11, Mar 11, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies to 2028' report from Jain PharmaBiotech has been added to [...]

Published
2020

7. Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies to 2028

Subjects
Precision medicine -- Health aspects, Drugs -- Health aspects, Anticonvulsants -- Health aspects, Aripiprazole -- Health aspects, Pharmacogenomics -- Health aspects, Technology, Levetiracetam, Primidone, Lamotrigine, Lacosamide, Patient monitoring equipment, Business, Business, international
Abstract

M2 PRESSWIRE-March 10, 2020-: Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies to 2028 (C)1994-2020 M2 COMMUNICATIONS RDATE:10032020 The 'Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies to 2028' report [...]

Published
2020

8. Therapeutic Drug Monitoring (TDM) Report, 2019: Worldwide Market Analysis (2018-2028) with Profiles on 35 Players

Subjects
Precision medicine -- Health aspects, Drugs -- Health aspects, Memantine -- Health aspects, Anticonvulsants -- Health aspects, Aripiprazole -- Health aspects, Pharmacogenomics -- Health aspects, Technology, Levetiracetam, Primidone, Lamotrigine, Lacosamide, Patient monitoring equipment, Business, Business, international
Abstract

M2 PRESSWIRE-August 26, 2019-: Therapeutic Drug Monitoring (TDM) Report, 2019: Worldwide Market Analysis (2018-2028) with Profiles on 35 Players (C)1994-2019 M2 COMMUNICATIONS RDATE:26082019 The 'Therapeutic Drug Monitoring - Technologies, Markets [...]

Published
2019

9. Prolaris(R) Test Accurately Predicts Risk of Metastasis in Men Diagnosed with Localized Prostate Cancer

Subjects
Myriad Genetics Inc., Precision medicine -- Health aspects, Cancer research -- Health aspects, Biotechnology industries -- Health aspects, Prostate cancer -- Health aspects, Pharmacogenomics -- Health aspects, Cancer metastasis -- Health aspects, Chairpersons, Banking, finance and accounting industries, Business
Abstract

SALT LAKE CITY, June 27, Jun 27, 2019 (GLOBE NEWSWIRE via COMTEX) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced publication of results from [...]

Published
2019

10. Therapeutic Drug Monitoring Technologies, Markets & Companies, 2019 Research Report - ResearchAndMarkets.com

Subjects
Pharmacogenomics -- Health aspects, Memantine -- Health aspects, Gene therapy -- Health aspects, Aripiprazole -- Health aspects, Precision medicine -- Health aspects, Anticonvulsants -- Health aspects, Illegal drugs, Patient monitoring equipment, Lamotrigine, Drug abuse, Levetiracetam, Primidone, Technology, Lacosamide, Business, Business, international
Abstract

DUBLIN -- The 'Therapeutic Drug Monitoring - Technologies, Markets & Companies' report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report deals with therapeutic drug monitoring, a multi-disciplinary [...]

Published
2019

11. Therapeutic Drug Monitoring Technologies, Markets & Companies, 2019 Research Report

Subjects
Drugs -- Health aspects, Pharmacogenomics -- Health aspects, Memantine -- Health aspects, Gene therapy -- Health aspects, Aripiprazole -- Health aspects, Precision medicine -- Health aspects, Anticonvulsants -- Health aspects, Illegal drugs, Patient monitoring equipment, Lamotrigine, Levetiracetam, Primidone, Technology, Lacosamide, Business, Business, international
Abstract

M2 PRESSWIRE-March 20, 2019-: Therapeutic Drug Monitoring Technologies, Markets & Companies, 2019 Research Report (C)1994-2019 M2 COMMUNICATIONS RDATE:20032019 The 'Therapeutic Drug Monitoring - Technologies, Markets & Companies' report from Jain [...]

Published
2019

12. Myriad Announces Prequel(TM) Prenatal Screen with Expanded Aneuploidy Analysis for all 23 Chromosome Pairs

Subjects
Myriad Genetics Inc., Biotechnology industries -- Health aspects, Precision medicine -- Health aspects, Pharmacogenomics -- Health aspects, Chromosomes -- Health aspects, Women's health -- Health aspects, Pregnant women -- Health aspects, Banking, finance and accounting industries, Business
Abstract

SALT LAKE CITY, Feb 11, 2019 (GLOBE NEWSWIRE via COMTEX) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that its Myriad Women's Health subsidiary [...]

Published
2019

13. Data on COVID-19 Discussed by Researchers at University of Ferrara (Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19)

Subjects
Severe acute respiratory syndrome -- Prognosis, Genetic research -- Health aspects, Coronaviruses -- Health aspects, Angiotensins -- Health aspects, Pharmacogenomics -- Health aspects, COVID-19 -- Prognosis, Business, Health, Health care industry
Abstract

2020 OCT 4 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Fresh data on Coronavirus - COVID-19 are presented in a [...]

Published
2020

15. Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2018

Subjects
Drugs -- Health aspects, Pharmacogenomics -- Health aspects, Business, Business, international
Abstract

M2 PRESSWIRE-February 26, 2018-: Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2018 (C)1994-2018 M2 COMMUNICATIONS RDATE:26022018 The 'Therapeutic Drug Monitoring - Technologies, Markets, and Companies' report from Jain [...]

Published
2018

16. Therapeutic Drug Monitoring Technologies, Markets, and Companies, 2026

Subjects
Precision medicine -- Health aspects, Drugs -- Health aspects, Pharmacogenomics -- Health aspects, Banking, finance and accounting industries, Business
Abstract

Dublin, Dec 14, 2017 (GLOBE NEWSWIRE via COMTEX) -- The 'Therapeutic Drug Monitoring - Technologies, Markets, and Companies' report from Jain PharmaBiotech has been added to Research and Markets' offering. [...]

Published
2017

17. Medicare Coverage of Prolaris(R) Test Expands with the Addition of Men Diagnosed with Favorable Intermediate Risk Prostate Cancer

Subjects
Myriad Genetics Inc., Precision medicine -- Health aspects, Medicare -- Health aspects, Biotechnology industries -- Health aspects, Prostate cancer -- Health aspects, Pharmacogenomics -- Health aspects, Banking, finance and accounting industries, Business
Abstract

SALT LAKE CITY, May 25, May 25, 2017 (GLOBE NEWSWIRE via COMTEX) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, [...]

Published
2017

18. Myriad Genetics to Present Results from Four Studies at the American Urological Association 2017 Annual Meeting

Subjects
Myriad Genetics Inc., Precision medicine -- Health aspects, Cancer research -- Health aspects, Biotechnology industries -- Health aspects, Pharmacogenomics -- Health aspects, Banking, finance and accounting industries, Business, American Urological Association
Abstract

SALT LAKE CITY, May 05, May 05, 2017 (GLOBE NEWSWIRE via COMTEX) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it will [...]

Published
2017

20. Therapeutic Drug Monitoring Report 2017 - Technologies, Markets, and Companies 2015-2026

Subjects
Precision medicine -- Health aspects, Gene therapy -- Health aspects, Drugs -- Health aspects, Pharmacogenomics -- Health aspects, Banking, finance and accounting industries, Business
Abstract

Dublin, Feb 21, 2017 (GLOBE NEWSWIRE via COMTEX) -- Research and Markets has announced the addition of Jain PharmaBiotech's new report 'Therapeutic Drug Monitoring - Technologies, Markets, and Companies' to [...]

Published
2017

21. Global Pharmacogenomics (PGx) Market Analysis 2016-2022: Ecosystem Players (Diagnostic Test, Pharmaceutical & Others) & Therapeutic Applications (Oncology, Cardiovascular & Others) - Research and Markets

Subjects
Pharmacogenomics -- Health aspects, Business, News, opinion and commentary
Abstract

DUBLIN, May 12, 2016 /PRNewswire/ --Research and Markets has announced the addition of the http://www.researchandmarkets.com/research/6qsc8q/global report to their offering. Global Pharmacogenomics (PGx) Market Analysis: Focus on Ecosystem Players (Diagnostic Test, [...]

Published
2016

22. Research and Markets - Global Therapeutic Drug Monitoring Market Report 2016-2020 - Major Players are F. Hoffmann-La Roche, Siemens, Thermo Fisher Scientific, Bio-Rad Labs & Danaher

Subjects
Thermo Fisher Scientific Inc., Danaher Corp., Control equipment industry -- Health aspects, Drugs -- Health aspects, Pharmacogenomics -- Health aspects, Scientific equipment industry -- Health aspects, Business, News, opinion and commentary
Abstract

DUBLIN, April 1, 2016 /PRNewswire/ -- Research and Markets has announced the addition of the http://www.researchandmarkets.com/research/mqvbgj/therapeutic_drug report to their offering. Major players in the therapeutic drug monitoring market include F. [...]

Published
2016

23. Global Therapeutic Drug Monitoring Market Is Projected to Grow at a CAGR of 7.4% to 2020

Subjects
Danaher Corp., Control equipment industry -- Health aspects, Drugs -- Health aspects, Pharmacogenomics -- Health aspects, Banking, finance and accounting industries, Business
Abstract

Dublin, March 31, Mar 31, 2016 (GLOBE NEWSWIRE via COMTEX) -- Research and Markets has announced the addition of the 'Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, [...]

Published
2016

24. Therapeutic Drug Monitoring 2015 - Technologies, Markets, and Companies Analysis 2014-2024

Subjects
Drugs -- Health aspects, Pharmacogenomics -- Health aspects, Business, Business, international
Abstract

M2 PRESSWIRE-March 5, 2015-: Therapeutic Drug Monitoring 2015 - Technologies, Markets, and Companies Analysis 2014-2024 (C)1994-2015 M2 COMMUNICATIONS RDATE:05032015 Dublin - Research and Markets (http://www.researchandmarkets.com/research/gnqcq9/therapeutic_drug) has announced the addition of [...]

Published
2015

25. Research and Markets: Therapeutic Drug Monitoring 2015 - Technologies, Markets, and Companies Analysis 2014-2024

Subjects
Drugs -- Health aspects, Pharmacogenomics -- Health aspects, Business, Business, international
Abstract

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/m99wg2/therapeutic_drug) has announced the addition of Jain PharmaBiotech's new report 'Therapeutic Drug Monitoring - Technologies, Markets, and Companies' to their offering. This report deals with [...]

Published
2015

26. Therapeutic Drug Monitoring Report 2015 - Technologies, Markets, and Companies Analysis

Subjects
Drugs -- Health aspects, Pharmacogenomics -- Health aspects, Banking, finance and accounting industries, Business
Abstract

Dublin, March 05, Mar 05, 2015 (GLOBE NEWSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/6z22gm/therapeutic_drug) has announced the addition of Jain PharmaBiotech's new report 'Therapeutic Drug Monitoring - Technologies, Markets, [...]

Published
2015

27. Global Therapeutic Drug Monitoring Report 2015 - Technologies, Markets, and Companies Analysis 2014-2024

Subjects
Pharmacogenomics -- Health aspects, Business, News, opinion and commentary
Abstract

DUBLIN, Mar. 05, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/vwvddw/therapeutic_drug ) has announced the addition of Jain PharmaBiotech's new report http://www.researchandmarkets.com/research/vwvddw/therapeutic_drug to their offering. This report deals with therapeutic drug monitoring, [...]

Published
2015

28. Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2014-2023 (Updated Report)

Subjects
Drugs -- Health aspects, Pharmacogenomics -- Health aspects, Business, Business, international
Abstract

M2 PRESSWIRE-December 3, 2014-: Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2014-2023 (Updated Report) (C)1994-2014 M2 COMMUNICATIONS RDATE:03122014 Dublin - Research and Markets (http://www.researchandmarkets.com/research/wgjf3n/therapeutic_drug) has announced the addition of [...]

Published
2014

29. Research and Markets: Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2014-2023 (Updated Report)

Subjects
Drugs -- Health aspects, Pharmacogenomics -- Health aspects, Business, Business, international
Abstract

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/623hzz/therapeutic_drug) has announced the addition of Jain PharmaBiotech's new report 'Therapeutic Drug Monitoring - Technologies, Markets, and Companies' to their offering. This report deals with [...]

Published
2014

30. Reports from S.M. Haghgoo and Co-Researchers Add New Data to Findings in Non-Small Cell Lung Cancer (Pharmacogenomics and targeted therapy of cancer: Focusing on non-small cell lung cancer)

Subjects
Cancer research -- Health aspects, Biochemistry -- Health aspects, Pharmacogenomics -- Health aspects, Non-small cell lung cancer -- Health aspects, Business, Health, Health care industry
Abstract

By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology have been published. According to news originating from Utrecht, Netherlands, by NewsRx correspondents, research stated, [...]

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results